NKGen Biotech To Reveal Positive SNK01 Biomarker Data At 2024 AAIC
orsonamiri
  • Reads 3
  • Votes 0
  • Parts 1
  • Time <5 mins
  • Reads 3
  • Votes 0
  • Parts 1
  • Time <5 mins
orsonamiri
Ongoing, First published Jul 19, 2024
biotechnology
NKGen Biotech, Inc. (Nasdaq: NKGN), a biotech firm specializing in autologous, allogeneic, and CAR-NK cell therapies, presents SNK01 biomarker data for Alzheimer's at AAIC 2024.
All Rights Reserved
biotechnology
Table of contents

1 part

Sign up to add NKGen Biotech To Reveal Positive SNK01 Biomarker Data At 2024 AAIC to your library and receive updates
or
#14biotechnology
Content Guidelines
You may also like
Brittanie's Writer Room by BrittanieCharmintine
15 parts Ongoing
A place for all things Brittanie!
You may also like
Slide 1 of 1
Brittanie's Writer Room cover

Brittanie's Writer Room

15 parts Ongoing

A place for all things Brittanie!

More details